Examples herein provide a syringe comprising a fluid reservoir and a male connector comprising a fluid flow channel in fluid communication with the fluid reservoir. The male connector including a male luer having a tapered sealing surface configured to mate with a female tapered surface of a female connector to form a substantially fluid-tight seal. The male luer has a distal tip with a recess defined by a recess surface that is distal to the tapered sealing surface. A water-soluble antimicrobial composition is disposed on the recess surface. The male luer is configured such that, when the male connector is mated with a female connector to form a substantially fluid-tight seal, a cavity is formed between the female tapered surface and the recess surface.

A catheter assembly may include a catheter adapter, which may include a distal end, a proximal end, a lumen extending through the distal end of the catheter adapter and the proximal end of the catheter adapter, and a side port disposed between the distal end of the catheter adapter and the proximal end of the catheter adapter. The catheter assembly may include a catheter extending distally from the distal end of the catheter adapter. The catheter assembly may include a valve disposed within the lumen. The catheter assembly may include a retainer element configured to secure the annular valve within the lumen. The retainer element may be disposed within the lumen proximal to a proximal end of the annular valve.

A fluid supply warning and communication system including a digital regulator in fluid tight engagement with a primary fluid reservoir. A method of using the fluid supply warning and communication system by flowing a fluid from a primary fluid reservoir to an end use appliance and detecting flow rate and pressure of the fluid with a digital regulator. A gas supply warning and communication system including an oxygen flow monitor that monitors SpO2, flow rate, pulse rate, and battery levels. A method of using the gas supply warning and communication system by flowing oxygen from a primary gas reservoir to an end use appliance, and measuring SpO2, flow rate, pulse rate, tank status, and battery levels.

The present invention includes a mask body having a cord attached at three locations on the mask body and a deformable bridge piece. The cord is attached at the middle of an upper edge of the mask body generally aligning with the location of the bridge of the wearer's nose. The cord is further attached at each of two lower positions on the mask body, preferably near or at the bottom corners of the mask body. The cord is further threaded through eyelets located at each of two upper positions on the mask body, preferably near or at the upper corners of the mask body. The deformable bridge piece is located along the upper edge of the mask body, and generally centered on the bridge of the wearer's nose.

Various embodiments disclosed relate to drug-coated balloon catheters for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent. In some embodiments, the balloon catheter includes a length-control mechanism which stretches and elongates the balloon when it is in a deflated state, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.

A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.

Environmental characteristics of habitable environments (e.g., hotel or motel rooms, spas, resorts, cruise boat cabins, offices, hospitals and/or homes, apartments or residences) are controlled to eliminate, reduce or ameliorate adverse or harmful aspects and introduce, increase or enhance beneficial aspects in order to improve a “wellness” or sense of “wellbeing” provided via the environments. Control of intensity and wavelength distribution of passive and active Illumination addresses various issues, symptoms or syndromes, for instance to maintain a circadian rhythm or cycle, adjust for “jet lag” or season affective disorder, etc. Air quality and attributes are controlled. Scent(s) may be dispersed. Hypoallergenic items (e.g., bedding, linens) may be used. Water quality is controlled. Noise is reduced and sounds (e.g., masking, music, natural) may be provided. Passive and active pathogen controls are employed. Controls are provided for the occupant and/or facility personnel, as is instruction, and surveys, including assessing wellness.

Provided is a fine particle generating apparatus outputting usage information, and in particular, a fine particle generating apparatus that generates fine particles through electrical heating and outputs usage information thereof to a user. Also, provided is a fine particle generating apparatus that generates fine particles by determining whether a puff has occurred according to a temperature variation amount per unit time. Also, provided is a fine particle generating apparatus or an aerosol generating apparatus capable of changing puff conditions by controlling a heater. Also, provided is a fine particle generating apparatus that generates fine particles through electrical heating.

A puncture site patch includes: an elastomeric, self-sealing membrane with an exterior face and interior face; a spacer including an outer face and inner face, where the outer face of the spacer is coupled to the interior face of the membrane, and where the spacer further includes an aperture forming a cavity defined by the interior face of the membrane, spacer, and skin when applied to a user; an adhesive film that can adhere to skin, the adhesive film on the inner face of the spacer; at least one elongated tab that can move between a first position and a second position; where when in the first position the at least one elongated tab extends outward from a periphery of the spacer; and where when in the second position the puncture site patch is folded so that the aperture is sealed closed by the at least one elongated tab.

Antiseptic caps that can be used to disinfect and/or protect medical connectors are disclosed herein. In some embodiments, the antiseptic cap can include a first chamber configured to be removably attached to the medical connector. Delivery systems for use with medical articles are also disclosed herein. In some embodiments, the delivery system comprises various dispensing systems for antiseptic caps and/or antiseptic cap holder assemblies. In some embodiments, the delivery system can be configured to permit the medical articles to be individually removable from the delivery system.